Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain ...Middle East

TAIPEI, Nov. 28, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switzerland AG ("Medvisis") in Switzerland and Liechtenstein, for exclusive rights to the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain )

Also on site :

• Diddy Trial Recap: Kid Cudi Testifies About Home Break-In and Porsche Molotov Cocktail Explosion
• Inside Mercedes-Benz’s plans to create a new HQ with hundreds of jobs in Atlanta
• Universal's Long-Awaited New Theme Park Finally Opens